מדינה: קנדה
שפה: אנגלית
מקור: Health Canada
L-ISOLEUCINE; L-LEUCINE; L-LYSINE (L-LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE; SERINE; N-ACETYL-L-TYROSINE; DEXTROSE
HOSPIRA HEALTHCARE ULC
B05BA10
COMBINATIONS
330MG; 500MG; 525MG; 85MG; 149MG; 200MG; 100MG; 230MG; 496MG; 509MG; 330MG; 369MG; 250MG; 150MG; 361MG; 265MG; 135MG; 25G
SOLUTION
L-ISOLEUCINE 330MG; L-LEUCINE 500MG; L-LYSINE (L-LYSINE ACETATE) 525MG; METHIONINE 85MG; L-PHENYLALANINE 149MG; L-THREONINE 200MG; TRYPTOPHAN 100MG; L-VALINE 230MG; L-ALANINE 496MG; L-ARGININE 509MG; L-ASPARTIC ACID 330MG; GLUTAMIC ACID 369MG; GLYCINE 250MG; HISTIDINE 150MG; L-PROLINE 361MG; SERINE 265MG; N-ACETYL-L-TYROSINE 135MG; DEXTROSE 25G
INTRAVENOUS
1000ML
Ethical
CALORIC AGENTS
Active ingredient group (AIG) number: 1850889011; AHFS:
CANCELLED POST MARKET
2012-08-03
PRESCRIBING INFORMATION AMINOSYN® II IN DEXTROSE INJECTION AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM NUTRIMIX® DUAL CHAMBER CONTAINERS Nutritive with and without Electrolyte Supplements for Intravenous Infusion Hospira Healthcare Corporation DATE OF PREPARATION: 5400 Côte-de-Liesse May 28, 2004 Town of Mount Royal (QC), CANADA H4P 1A5 Control#: 091791, 091794, 091796, 091797, 091802, 091806 - 2 - PRESCRIBING INFORMATION NAME OF DRUGS AMINOSYN® II IN DEXTROSE INJECTION AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM NUTRIMIX® DUAL CHAMBER CONTAINERS THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION Nutritive with and without Electrolyte Supplements for Intravenous Infusion CLINICAL PHARMACOLOGY Total parenteral nutrition consists of appropriate amino acids, electrolytes, trace metals, vitamins and an energy source. This may be accomplished by administering AMINOSYN® II (amino acids) with or without electrolytes, fat emulsion plus concentrated dextrose, vitamins and trace metals. AMINOSYN® II (an amino acid injection) with or without Electrolytes in Dextrose Injection with or without Calcium obtained after thoroughly mixing the contents of the two chambers provides carbohydrate calories and amino acids to promote protein synthesis and wound healing, to reduce the rate of endogenous protein catabolism and to minimize liver glycogen depletion. INDICATIONS AND CLINICAL USES 1. PERIPHERAL VEIN ADMINISTRATION AMINOSYN® II 3.5% in 5% Dextrose Injection and AMINOSYN® II 3.5% M (amino acid injection 3.5% with maintenance electrolytes) in 5% Dextrose Injection are indicated for peripheral vein infusion as a source of nitrogen in the intravenous treatment of acute surgical patients with adequate store of body fat, in whom, for short periods of time, oral nutrition cannot be tolerated or is not desirable. In such instances, the patients' energy needs are met from their ow קרא את המסמך השלם